AI-generated from publicly available materials.NEC has joined the EU-funded PREPAIR VAC initiative, focusing on enhancing pandemic preparedness through AI-driven vaccine design.
The PREPAIR VAC project, backed by Horizon Europe, aims to streamline vaccine development in response to emerging infectious diseases. With a budget of approximately €6.5 million, the four-year initiative includes NEC OncoImmunity, which will lead efforts in antigen prediction and AI-based vaccine design. The consortium, coordinated by the European Vaccine Initiative, comprises various organizations from manufacturing to ethical considerations surrounding vaccine innovation, including partners from France, Germany, and Sweden.
NEC's involvement underscores the importance of AI in anticipating viral evolution and creating vaccines that provide broader protection against variants. This initiative is part of a broader European strategy to enhance health resilience in light of the challenges revealed by the COVID-19 pandemic. By integrating academic institutions with industry partners, the project aims to connect early-stage research with practical applications in vaccine development.
Dr. Kaidre Bendjama, Chief Scientific Officer at NEC OncoImmunity, emphasized that the project reflects confidence in AI's role in pandemic preparedness. The focus on ethical and regulatory issues highlights the need for transparency in deploying AI in healthcare. Overall, the PREPAIR VAC project seeks to establish a rapid vaccine design pipeline, enabling health systems to respond more effectively to future infectious threats.